|
Volumn 336, Issue 6079, 2012, Pages 284-
|
Texas Medical Board approves rules for controversial treatment
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DISEASE TREATMENT;
GERM CELL;
HEALTH CARE;
HEALTH POLICY;
HEALTH SERVICES;
MEDICINE;
REGULATORY FRAMEWORK;
ADULT STEM CELL;
ARTHRITIS;
CLINICAL TRIAL (TOPIC);
FOOD AND DRUG ADMINISTRATION;
HUMAN;
INJURY;
JAPAN;
MEDICAL SOCIETY;
MULTIPLE SCLEROSIS;
PHYSICIAN;
PRIORITY JOURNAL;
SCIENTIST;
SHORT SURVEY;
STEM CELL TRANSPLANTATION;
UNITED STATES;
EXPERIMENTAL THERAPY;
GOVERNMENT;
LEGAL ASPECT;
NOTE;
PROFESSIONAL STANDARD;
TRANSPLANTATION;
TEXAS;
UNITED STATES;
ADULT STEM CELLS;
ETHICS COMMITTEES, RESEARCH;
HUMANS;
STATE GOVERNMENT;
STEM CELL TRANSPLANTATION;
TEXAS;
THERAPIES, INVESTIGATIONAL;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 84859930680
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.336.6079.284 Document Type: Short Survey |
Times cited : (6)
|
References (0)
|